Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  HIV Infection

  Free Subscription


19.08.2024

1 AIDS Res Hum Retroviruses
1 BMJ
1 Clin Infect Dis
2 HIV Med
1 Int J Cancer
1 Int J Dermatol
3 J Acquir Immune Defic Syndr
3 J Infect Dis
1 J Med Virol
2 J Virol
3 Lancet
1 PLoS Med
10 PLoS One
2 PLoS Pathog


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS Res Hum Retroviruses

  1. NGUYEN L, Leach A, Piwowar-Manning E, Marzinke MA, et al
    Strengthening the Application of the DAIDS GCLP Guidelines: The Implementation of an Integrated Laboratory Oversight Framework.
    AIDS Res Hum Retroviruses. 2024 Aug 13. doi: 10.1089/AID.2024.0042.
    PubMed         Abstract available


    BMJ

  2. DYER O
    HIV: Breakthrough study raises hopes of effective prevention if drug's cost can be lowered.
    BMJ. 2024;386:q1776.
    PubMed        


    Clin Infect Dis

  3. GRISEL B, Kaur K, Swain S, Gorenshtein L, et al
    The Ethical Obligation to Treat Infectious Patients: A Systematic Review of Reasons.
    Clin Infect Dis. 2024;79:339-347.
    PubMed         Abstract available


    HIV Med

  4. WHITE TM, Fuster-RuizdeApodaca MJ, Iniesta C, Prats-Silvestre C, et al
    Network analysis to prioritize issues for intervention to improve the health-related quality of life of people with HIV in Spain.
    HIV Med. 2024 Aug 10. doi: 10.1111/hiv.13693.
    PubMed         Abstract available

  5. CHAN CK, Huang SS, Wong KH, Leung CC, et al
    No increased risk of tuberculosis-related immune reconstitution inflammatory syndrome with integrase inhibitor-based antiretroviral therapy in people with HIV with profound immunosuppression.
    HIV Med. 2024 Aug 12. doi: 10.1111/hiv.13695.
    PubMed         Abstract available


    Int J Cancer

  6. DUSINGIZE JC, Murenzi G, Muhoza B, Businge L, et al
    Cancer risk among people living with Human Immuodeficiency Virus (HIV) in Rwanda from 2007 to 2018.
    Int J Cancer. 2024 Aug 11. doi: 10.1002/ijc.35091.
    PubMed         Abstract available


    Int J Dermatol

  7. SOUGHI M, Samira R, Elloudi S, Bennouna Z, et al
    An atypical cutaneous manifestation of visceral leishmaniasis in an HIV patient.
    Int J Dermatol. 2024 Aug 9. doi: 10.1111/ijd.17429.
    PubMed        


    J Acquir Immune Defic Syndr

  8. SAVINELLI S, McGettrick P, Garcia Leon AA, Tinago W, et al
    Obesity is associated with higher levels of circulating cytokines involved in the development of cardiovascular disease in people living with HIV.
    J Acquir Immune Defic Syndr. 2024 Aug 15. doi: 10.1097/QAI.0000000000003508.
    PubMed         Abstract available

  9. RUSSELL ES, Zhou M, Song Y, Barak N, et al
    Patterns of HIV treatment preferences among people with diverse demographic, social, and behavioral characteristics who are living with HIV in the United States.
    J Acquir Immune Defic Syndr. 2024 Aug 15. doi: 10.1097/QAI.0000000000003509.
    PubMed         Abstract available

  10. ISLAS-MUNOZ B, Chavez-Galan L, Ramon-Luing L, Flores-Gonzalez J, et al
    Comparison of IL-6, IL-10, and TNFalpha levels between PLWHIV with and without Kaposi Sarcoma and healthy controls.
    J Acquir Immune Defic Syndr. 2024 Aug 15. doi: 10.1097/QAI.0000000000003507.
    PubMed         Abstract available


    J Infect Dis

  11. DESISTO CL, Winer RL, Querec TD, Dada D, et al
    Vaccine effectiveness against anal HPV among men who have sex with men aged 18-45 years attending sexual health clinics in three United States cities, 2018-2023.
    J Infect Dis. 2024 Aug 8:jiae394. doi: 10.1093.
    PubMed         Abstract available

  12. D'ENTREMONT-HARRIS M, Ramsey TD, Pelletier E, Goodall B, et al
    Reply to Antinori and Bausch-Jurken.
    J Infect Dis. 2024;230:524-526.
    PubMed        

  13. REID TB, Godornes C, Campbell VL, Laing KJ, et al
    Treponema pallidum Periplasmic and Membrane Proteins Are Recognized by Circulating and Skin CD4+ T Cells.
    J Infect Dis. 2024 Jun 27:jiae245. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  14. PIETROLUONGO E, Luciano A, Peddio A, Buonaiuto R, et al
    Exploring the interplay between Kaposi's sarcoma and SARS-CoV-2 infection: A case series and systematic review.
    J Med Virol. 2024;96:e29849.
    PubMed         Abstract available


    J Virol

  15. MUECKSCH F, Klaus S, Laketa V, Muller B, et al
    Probing Gag-Env dynamics at HIV-1 assembly sites using live-cell microscopy.
    J Virol. 2024 Aug 13:e0064924. doi: 10.1128/jvi.00649.
    PubMed         Abstract available

  16. MU Z, Whitley J, Martik D, Sutherland L, et al
    Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designs.
    J Virol. 2024 Aug 13:e0013724. doi: 10.1128/jvi.00137.
    PubMed         Abstract available


    Lancet

  17. MODY A, Sohn AH, Iwuji C, Tan RKJ, et al
    The battle against paediatric HIV is far from over - Authors' reply.
    Lancet. 2024;404:522-523.
    PubMed        

  18. VAN DE PERRE P, Tylleskar T
    The battle against paediatric HIV is far from over.
    Lancet. 2024;404:522.
    PubMed        

  19. NABAYINDA J, Kizito S, Nagawa A, Ssewamala FM, et al
    Reducing HIV in young women in Uganda: the need for autonomy.
    Lancet. 2024;404:519-520.
    PubMed        


    PLoS Med

  20. ODHIAMBO F, Onyango R, Mulwa E, Aluda M, et al
    Evaluation of person-centered interventions to eliminate perinatal HIV transmission in Kisumu County, Kenya: A repeated cross-sectional study using aggregated registry data.
    PLoS Med. 2024;21:e1004441.
    PubMed         Abstract available


    PLoS One

  21. ZENERE G, Wu C, Midkiff CC, Johnson NM, et al
    Extracellular domain, hinge, and transmembrane determinants affecting surface CD4 expression of a novel anti-HIV chimeric antigen receptor (CAR) construct.
    PLoS One. 2024;19:e0293990.
    PubMed         Abstract available

  22. MARTINS N, Soares D, Gusmao C, Nunes M, et al
    A qualitative exploration of the impact of the COVID-19 pandemic on gender-based violence against women living with HIV or tuberculosis in Timor Leste.
    PLoS One. 2024;19:e0306106.
    PubMed         Abstract available

  23. VAN GERWEN OT, Sherman ZA, Kay ES, Wall J, et al
    Recruiting transgender men in the Southeastern United States for genital microbiome research: Lessons learned.
    PLoS One. 2024;19:e0308603.
    PubMed         Abstract available

  24. DRAKE AL, Jiang W, Kitao P, Farid S, et al
    Preferences and uptake of home-based HIV self-testing for maternal retesting in Kenya.
    PLoS One. 2024;19:e0302077.
    PubMed         Abstract available

  25. MAVISO M
    Prevalence and predictors of HIV testing among young men in Papua New Guinea: A cross-sectional analysis of a nationally representative sample.
    PLoS One. 2024;19:e0306807.
    PubMed         Abstract available

  26. KAMORI D, Barabona G, Maokola W, Rugemalila J, et al
    HIV viral suppression in the era of dolutegravir use: Findings from a national survey in Tanzania.
    PLoS One. 2024;19:e0307003.
    PubMed         Abstract available

  27. OJO JO, Ipinnimo TM, Afolayan AC, Adewoye KR, et al
    Factors associated with willingness to use mHealth interventions for medication adherence among people living with HIV attending a tertiary hospital in sub-Saharan Africa.
    PLoS One. 2024;19:e0309119.
    PubMed         Abstract available

  28. LEPINE A, Procureur F, Szawlowski S, Treibich C, et al
    Optimising the public health benefits of sex work regulation in Senegal: Results from qualitative interviews with policy stakeholders.
    PLoS One. 2024;19:e0306803.
    PubMed         Abstract available

  29. WEREKUU A, Ayisi-Boateng NK, Tagoe N, Opoku DA, et al
    KNUST aging and human immunodeficiency virus outcomes-Study protocol.
    PLoS One. 2024;19:e0307719.
    PubMed         Abstract available

  30. CHERKOS AS, LaCourse SM, Enquobahrie DA, Escudero JN, et al
    Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial.
    PLoS One. 2024;19:e0293708.
    PubMed         Abstract available


    PLoS Pathog

  31. ZHOU Z, Guo J, Hetrick B, Tiwari S, et al
    Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties.
    PLoS Pathog. 2024;20:e1012448.
    PubMed         Abstract available

  32. VAN DER STRATEN K, Guerra D, Kerster G, Claireaux M, et al
    Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.
    PLoS Pathog. 2024;20:e1012453.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.